Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Summary

The purpose of this study is to see if it is safe and effective to give zintevir (AR177) to asymptomatic (no symptoms) HIV-infected patients. Zintevir belongs to a new class of anti-HIV drugs, the integrase inhibitors. HIV uses the protein integrase to infect a cell. Integrase inhibitors block integrase and may stop replication of HIV.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications